A single institution experience of streptozocin/fluorouracil combination chemotherapy : a case series
Naidoo, J., O'Toole, D., Kennedy, M. J., Reynolds, J. V., O'Connor, M., & O'Byrne, Kenneth J. (2012) A single institution experience of streptozocin/fluorouracil combination chemotherapy : a case series. Irish Journal of Medical Science, 181(2), pp. 211-214.
Background The combination chemotherapy regimen of streptozocin and 5-fluorouracil (FU/STZ) has been used for the treatment of metastatic neuroendocrine tumours.
Aim The aim of this study was to analyse the use of this regimen in a tertiary oncology referral centre over a 10-year period.
Method We retrospectively analysed nine cases from February 2000 to May 2010. Patient demographics, chemotherapy schedule, toxicities, progression-free and overall survival were tabulated for each patient.
Result The median progression-free survival was 17 months (range 3-48+ months), and overall survival 31 months (range 12-53+ months) with no toxicity related deaths.
Conclusion FU/STZ was a well-tolerated regimen that produced significant benefit in the setting of metastatic and progressive disease. Our case series demonstrated comparable progression-free survival and overall survival in relation to randomized controlled studies and previous case series. © Royal Academy of Medicine in Ireland 2011.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Fluorouracil, Metastatic, Neuroendocrine, Streptozocin, Tumour, dacarbazine, doxorubicin, adult, aged, alopecia, anemia, article, clinical article, combination chemotherapy, demography, diarrhea, drug tolerability, endocrine disease, fatigue, female, human, intestine obstruction, kidney disease, leukopenia, male, metastasis, mucosa inflammation, multiple cycle treatment, nausea, neuroendocrine tumor, neutropenia, overall survival, progression free survival, retrospective study, sepsis, skin disease, thrombocytopenia, treatment outcome, vomiting, Antibiotics, Antineoplastic, Antimetabolites, Antineoplastic, Carcinoid Tumor, Disease-Free Survival, Drug Therapy, Combination, Humans, Middle Aged, Neuroendocrine Tumors|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2012 Springer U K|
|Deposited On:||09 Dec 2013 06:18|
|Last Modified:||16 Mar 2014 23:18|
Repository Staff Only: item control page